Metformin failure in people with type 2 diabetes is very common, especially in those with elevated A1c levels at diagnosis, new findings suggest. An analysis of electronic health record data from more than 22,000 patients starting metformin at three US clinical sites found that more than 40% experienced metformin failure. This was defined as the …
Metformin monotherapy not always the best start in type 2 diabetes Read More »
There are some potentially serious benefits and risks associated with complementary and alternative medicine (CAM) that patients with heart failure (HF) can use to manage symptoms, the American Heart Association (AHA) says in a new scientific statement on the subject. For example, yoga and tai chi may be helpful for people with heart failure, and …
New AHA Statement on Complementary Medicine in Heart Failure Read More »
Perceived discrimination — unfair treatment because of their race, gender, ethnicity, socioeconomic status, or other factors — in daily life was common among young survivors of myocardial infarction (MI) and was associated with poorer recovery, new research shows. In this study, patients completed three questionnaires assessing perceived discrimination, general mental and physical health, physical health, …
Perceived discrimination linked to worse recovery after MI in young people Read More »
Editor’s Note: Find the latest COVID-19 news and advice in Medscape’s Coronavirus Resource Center. Annual deaths from heart disease in the United States increased in 2020 during the COVID pandemic, after a steady decline over the previous decade, a new study has found. The heart disease death rate in the general population rebounded in 2020 …
Deaths from heart disease have increased during COVID after 10 years of decline Read More »
Dr. Kiana Aran, courtesy of Keck Graduate Institute (KGI) As a young woman in Iran, Dr. Kiana Aran made the choice to study electrical engineering. She didn’t know it at the time, but it would lead her to her true passion: biology. It was also the decision that ultimately led her to achieve significant breakthroughs …
Breaking Down Silos: How One Physician Is Reshaping Medicine | BioSpace Read More »
Dr. Kiana Aran, courtesy of Keck Graduate Institute (KGI) As a young woman in Iran, Dr. Kiana Aran made the choice to study electrical engineering. She didn’t know it at the time, but it would lead her to her true passion: biology. It was also the decision that ultimately led her to achieve significant breakthroughs …
Breaking Down Silos: How One Physician Is Reshaping Medicine | BioSpace Read More »
This transcript has been edited for clarity. I am Dr. Neil Skolnik. Today we are going to talk about the consensus report from the American Diabetes Association and the European Association for the Study of Diabetes on the management of hyperglycemia. A lot has changed in this consensus statement. It covers a lot of ground. …
New recommendations for the management of hyperglycemia Read More »
Interim Results Show Sustained Reduction in Hereditary Angioedema Attacks and No New Safety Signals in Patients Treated for One Year CARLSBAD, Calif., Nov. 13, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported positive results from a Phase 2 open-label extension (OLE) study evaluating the safety and efficacy of its investigational antisense drug, donidalorsen, …
A new Japanese study of highly purified eicosapentaenoic acid (EPA; icosapent ethyl) has suggested a possible benefit in reducing adverse cardiovascular events in patients with chronic coronary heart disease taking statins. The randomized, open-label RESPECT-EPA study showed reduction in borderline statistical significance in its primary endpoint of a composite of cardiovascular death, nonfatal myocardial infarction …
New Trial Suggests CV Benefit With EPA: RESPECT-EPA Read More »
TEL AVIV, Israel, October 24, 2022 /PRNewswire/ — Lutris Pharma, a clinical-stage biopharmaceutical company focused on improving cancer therapies by reducing dose-limiting side effects, today announced that the California Institute of Regenerative Medicine (CIRM) has awarded the founder and chairman of the company’s board of directors, Antoine RibasMD, Ph.D., Professor of Medicine, Professor of Surgery, …
